Keys to managing regulatory affairs in a global MAA project

Globe representing worldwide access to medicines

Marketing authorisation application checklist for Global Regulatory Affairs Directors Planning and delivering pharmaceutical product approvals across regions globally is not an easy undertaking. Fortunately, at Arex Advisor we are experienced in multiple facets of the process. Below, we have listed some of the key factors to ensure success, and how to steer clear of common […]

CMC in a global MAA project – what to keep on your radar

Medicines bottles being manufactured

Marketing authorisation application checklist for Global Regulatory Affairs Directors Our MAA services The CMC section of the regulatory dossier stands as one of the cornerstones for achieving a successful global MAA for pharmaceutical products. Regulatory Affairs Directors must often navigate a labyrinth of requirements to ensure compliance across diverse markets, while maintaining the highest standards of […]

A guide to labelling in global MAA projects

Medicines on a shelf illustrating pharma labelling

Marketing authorisation application checklist for Global Regulatory Affairs Directors Effective labelling is not just a regulatory necessity, it’s essential for patient trust and product success. In this article, we aim to share valuable insights on vital labelling considerations, common pitfalls, and best practices to help guide you toward a seamless MAA/NDA/BLA experience. Related articles:Keys to […]

Linnea Brodin

Finance Manager

BSc Business and Economics

Linnea is our Finance Manager. She has a BSc in Business and Economics from Södertörns University and has previously worked in the accounts payable department at Huddinge Kommun.

Staffan Thunell

Founding partner

BSc Economics and BA

Staffan has a long background in entrepreneurship within the life science industry. He has 20+ years experience from posit­ions as Founder, Chair­man, CEO and CFO within medical affairs consulting and small pharma. Previously Staffan worked in executive positions in big pharma and specialty pharma companies.